ABT - Abbott Laboratories
261
$107.19
-$1.30 (-1.198%)
$107.01
-$0.18 (-0.167%)
Score3.79/5
Ownership Breakdown
Type | % Ownership | Market Value |
|---|---|---|
Insider | 0.47% | $879.53M |
Institutional | 81.83% | $152.42B |
Common & Other | 17.70% | $32.97B |
Insider Transactions
Executive Salaries
Name | Compensation | Position(s) | Appointed | Age |
|---|
| Robert Ford | $22,777,075 | Chairman of the Board, Chief Executive Officer | 2014 | 51 |
| Philip Boudreau | $8,225,746 | Chief Financial Officer, Executive Vice President - Finance | 52 | |
| Hubert Allen | $7,981,335 | Executive Vice President, General Counsel, Secretary | 59 | |
| Mary Moreland | -- | Executive Vice President - Human Resources | 58 | |
| Lisa Earnhardt | $6,558,461 | Executive Vice President, Group President - Medical Devices | 55 | |
| Louis Morrone | -- | Executive Vice President - Core Diagnostics | 48 | |
| Daniel Salvadori | $5,789,762 | Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products | 46 | |
| Andrea Wainer | $6,287,118 | Executive Vice President - Rapid and Molecular Diagnostics | 56 | |
| Randel Woodgrift | -- | Senior Vice President - Cardio Rhythm Management | 62 | |
| John Mccoy | -- | Vice President - Finance, Controller | 55 | |